KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Goodwill & Intangibles (2016 - 2025)

Travere Therapeutics (TVTX) has disclosed Goodwill & Intangibles for 13 consecutive years, with $109.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Goodwill & Intangibles changed N/A year-over-year to $109.4 million, compared with a TTM value of $109.4 million through Sep 2025, changed N/A, and an annual FY2022 reading of $145.8 million, down 1.75% over the prior year.
  • Goodwill & Intangibles was $109.4 million for Q3 2025 at Travere Therapeutics, up from $800000.0 in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $162.9 million in Q1 2023 and bottomed at $800000.0 in Q2 2024.
  • Average Goodwill & Intangibles over 5 years is $89.1 million, with a median of $109.4 million recorded in 2025.
  • The sharpest move saw Goodwill & Intangibles soared 17998.11% in 2023, then crashed 99.48% in 2024.
  • Year by year, Goodwill & Intangibles stood at $148.4 million in 2021, then dropped by 1.75% to $145.8 million in 2022, then decreased by 26.7% to $106.9 million in 2023, then tumbled by 99.25% to $800000.0 in 2024, then skyrocketed by 13579.37% to $109.4 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for TVTX at $109.4 million in Q3 2025, $800000.0 in Q2 2025, and $800000.0 in Q1 2025.